CombiGene´s lead project CG01 has received funding from the European Union´s Horizon 2020 research and innovation programme

CombiGene’s CEO Jan Nilsson guests AstraZeneca Exchange

May 16, 2019

The AstraZeneca Exchange networking events are held at AstraZeneca’s strategic R&D hubs in Gothenburg, Sweden and Cambridge, UK. The events are designed to provide opportunities for representatives from across the life science community to share knowledge and ideas. CombiGene’s CEO Jan Nilsson was invited on May 14th, together with Professor Johan Hyllner, Head of Regeneration, Early CVRM, R&D BioPharmaceuticals AstraZeneca (former Chief Scientific Officer at British CGT Catapult) and Professor Helena Brisby, Chief Physician, University of Gothenburg & Sahlgrenska University Hospital, to give a presentation under the heading Delivering advanced medicines to patients.

“To be invited to represent CombiGene at AstraZeneca Exchange is a very valuable expeprience,” says Jan Nilsson. “First of all, it is acknowledgement of the fact that CombiGene’s activities are gaining recognition in the industry, which is extremely gratifying. Secondly, it gives us fantastic opportunities to network with knowledgeable people. The event in Gothenburg gave me several new and valuable contacts and also exemplified how interest in gene therapy continues to grow.”